Use the ASCO/ESMO Global Curriculum to structure learning and discuss the ITE feedback with your trainer. Review the official registration guide and proctor arrangements. ASCO describes the assessment as a snapshot of knowledge, not an individual board certification.
American Society of Clinical Oncology
ASCO Medical Oncology In-Training Examination
A low-stakes self-evaluation and programme-improvement assessment; it has no pass/fail certification. Irish Medical Oncology HST trainees should sit it at least once, preferably annually. The ESMO examination is a separate recommended assessment.
Examining body: American Society of Clinical Oncology
Who can sit it
Trainees first update their ASCO account and obtain Member-in-Training membership; programme administrators then complete enrolment. Follow ASCO’s two-stage registration instructions.
When NCHDs sit it
At least once during Irish HST, preferably annually. The 2027 administration is 23–24 February; registration opens in November 2026.
Exam format
Dates
- 1 Feb 2027Apply by2027 registration closes (MedOnc ITE)
- 23 Feb 2027SittingMedOnc ITE 2027 window opens (23–24 February; choose one day) (MedOnc ITE)
Training links
Required to sit. Sit at least once during HST, preferably annually. This is an assessment of progress during training.
Preparation resources
College guidance, question banks, books and courses, grouped by format. Descriptions identify their coverage; provider pages give current prices and access terms.
College guidance
Official administration and registration instructions.
Curriculum framework for medical oncology training.
Check the provider for current prices and access terms. No affiliate links.
Preparing
Facts last verified 2026-10-25.
Further reading
- HST Medical Oncology
Required to sit
- Training funds
The HSE education funding schemes for NCHDs: allowances by grade, eligible expenses, and how to claim.
- Postgraduate exams
Exam formats, eligibility and preparation resources.